The Graft

ALL EPISODES AS VIDEO
https://youtu.be/La-723RhDIA
CONNECT WITH US
https://twitter.com/TheEBMT_Trainee
https://www.ebmt.org/trainee-committee
https://twitter.com/NicoGagelmann
https://twitter.com/Claire_P_Horgan

FOLLOW MLL
Twitter: @leukaemielabor
mll.com

FOLLOW Daniela Twitter: @HermelinMD https://www.bloodcenter.org/about/news/authors/daniela-hermelin-md-a7/ https://www.blooducation.com/about-dr-hermelin ALL EPISODES AS AUDIO APPLE https://podcasts.apple.com/de/podcast/the-graft/id1543609846 SPOTIFY https://open.spotify.com/show/2x2ovFm0cG0NmgyItygbab GOOGLE https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy80Mjk1MzA1Yy9wb2RjYXN0L3Jzcw== CONNECT WITH US https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/NicoGagelmann https://twitter.com/Claire_P_Horgan

https://twitter.com/AbbasiMuqtadir

CONNECT WITH US

https://twitter.com/TheEBMT_Trainee

https://www.ebmt.org/trainee-committee

https://twitter.com/NicoGagelmann

https://twitter.com/Claire_P_Horgan

Dr. Brudno researches the use of chimeric antigen receptor (CAR) T-cell therapy to treat cancers of the blood, including Non-Hodgkin lymphoma, Hodgkin lymphoma, acute lymphoblastic leukemia (ALL), and multiple myeloma. Her focus is in the development of phase I clinical trials. She is also interested in patient safety, particularly in optimizing patient safety for cellular immunotherapies.

Nico Gagelmann and Jennifer Brudno

ALL EPISODES AS AUDIO

APPLE https://podcasts.apple.com/de/podcast/the-graft/id1543609846

SPOTIFY https://open.spotify.com/show/2x2ovFm0cG0NmgyItygbab

GOOGLE https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy80Mjk1MzA1Yy9wb2RjYXN0L3Jzcw==

CONNECT WITH US

https://twitter.com/TheEBMT_Trainee

https://www.ebmt.org/trainee-committee

https://twitter.com/NicoGagelmann

https://twitter.com/Claire_P_Horgan